Copyright: ©Author(s) 2027.
World J Gastroenterol. Jan 7, 2027; 33(1): 123034
Published online Jan 7, 2027. doi: 10.3748/wjg.123034
Published online Jan 7, 2027. doi: 10.3748/wjg.123034
Table 1 Orthogonal least partial squares discriminant analysis model parameters
| Model | Group | R2Y value | Q2 value | ||||
| Serum | Liver | Urine | Serum | Liver | Urine | ||
| ESI+ | CON vs MOD | 0.998 | 0.998 | 0.998 | 0.777 | 0.866 | 0.968 |
| FZD vs MOD | 0.997 | 0.994 | 0.997 | 0.799 | 0.412 | 0.962 | |
| ESI- | CON vs MOD | 0.998 | 0.992 | 0.993 | 0.873 | 0.882 | 0.962 |
| FZD vs MOD | 0.999 | 0.998 | 0.998 | 0.906 | 0.576 | 0.979 | |
- Citation: Wang PQ, Yang H, Tang YM, Tao YX, Han SC, Zhou QD, Yu J, Yang XX. Mechanisms of Fuling Zexie decoction against metabolic dysfunction-associated steatotic liver disease: Integrative metabolomics, gut microbiota and serum pharmacochemistry. World J Gastroenterol 2027; 33(1): 123034
- URL: https://www.wjgnet.com/1007-9327/full/v33/i1/123034.htm
- DOI: https://dx.doi.org/10.3748/wjg.123034